Supplemental Digital Content is available in the text
Keywords: Alzheimer disease, homocysteine, prevalence, vitamin B
Abstract
Alzheimer disease (AD) is the most common neurodegenerative disease in the world. The relationship between AD and homocysteine (Hcy) is contradictory.
A community-based investigation was conducted to find patients with AD in a vitamin B deficient population (≥55 years old) in Lüliang area in China. Venous blood samples were collected. Serum Hcy, folate, and vitamin B12 were measured. For each case, 4 controls were selected matched with age to evaluate the relationship between Hcy and AD.
The crude prevalence of AD among people ages 55 years or older in this area was 8.60%. There were significant differences in serum Hcy and B12 between the case and control groups. We found that the higher level of serum Hcy was associated with a high risk of AD, and higher education level, higher folate and B12 concentration were protective factors to AD.
Adjustment of diet structure and supplementation of folate and B12 may offer potential therapeutic measures in this area.
1. Introduction
Alzheimer disease (AD), the most common neurodegenerative disorder in the elderly, has tremendous consequences on individuals, families, and society.[1,2] With the increasing proportion of the elderly, the number of AD will grow up to 3-fold by 2050.[3] The World Health Organization estimates that the prevalence of AD in the elderly, older than 65 years, is 4% to 7%, which is about 3.21% in China. Because of large population base, AD has become a major public health problem in China. The etiology of AD, however, remains unknown after decades of efforts. Epidemiological studies have found that many factors are related to AD, such as age, gene, sex, education, metabolic factors, mental factors, and dietary factors. It is meaningful to identify modifiable risk factors for this disease.
Homocysteine (Hcy) is formed by demethylation of methionine. There is a close relationship between Hcy and folate, B6, and B12 vitamin levels, which act as the coenzymes of methionine and Hcy metabolism. Deficiency of these B vitamins have been associated with increased Hcy,[4] which is known to have a neurotoxic effects and associated with many diseases, such as cardiovascular diseases and neurodegenerative diseases.[5,6] Up to now, the relationship between Hcy and cognitive impairment is still controversial. Some studies[7–11] have demonstrated that elevated Hcy is related to cognitive decline, whereas other studies[12] found no association between them.
Lüliang area is a folate and B12 deficient area,[13] which may have a high proportion of hyperhomocysteinemia. Meanwhile, we presumed that there will be more cognitive impairment cases in this region. Thus it is a proper area to investigate the relationship between cognitive impairment and Hcy. Furthermore, the data about prevalence of cognitive impairment in Shanxi province were lacking. Similar researches were performed in large cities, such as Beijing, Shanghai, and Xi’an before.
In the present study, we conducted a cross-sectional design to investigate the prevalence of AD in people older than 55 years in Lüliang area and a case-control study to explore the relationship between serum B vitamins, Hcy, and AD.
2. Materials and methods
2.1. Study design and participants
This was a cross-sectional study to investigate the prevalence of AD and the relationship between Hcy and AD in a B12 and folate deficient population in Lüliang, China. Lüliang is a mountainous region, which is underdeveloped, and 80% of residents live in rural areas. Three towns (Gaojiagou, Kangcheng, Caijiaya) were selected as the target populations according to the geographic location (Center, South, North). There was no running water supply and all people drank well water there. Inclusion criteria are the following: we got a population list from the household registry department. People over 55 years old living in Lüliang area for >2 months per year were included in our study. When studying the relationship between Hcy and cognition, exclude people who usually supplement vitamin B.
All participants signed the informed consent. The study was approved by the Ethics Committee of the First Hospital, Shanxi Medical University.
2.2. Questionnaire and cognition evaluation
Trained interviewers (neurologists and senior clinical medical students) administrated a self-designed questionnaire for participants in township hospital. Demographic and medical information was collected, including age, sex, education, marital status, smoking and drinking habits, health situation, and drug use. Education was summarized as illiteracy and literacy. Smoking was divided into 3 categories: never, former, current. Current smokers were defined as participants who smoke ≥1 cigarette/day for ≥6 months; former smokers were defined as participants who smoke <1 cigarette/day or have quit the habit ≥6 months; and participants who never smoke were defined as never. Drinking was also divided into 3 categories: never, former, current. Current drinkers were defined as participants who drink at least once a week for ≥6 months; former drinkers were defined as participants who drink less than once a week or have quit the habit for ≥6 months; and participants who never drink were defined as never.
Cognitive function was evaluated by Chinese versions of the Mini-Mental State Examination (MMSE). MMSE is a global measurement for cognition: orientation in time and place, memory, language, calculation, and constructional praxis. The scores range from 0 (worst) to 30 (best). For people did not appear in the township clinics, investigators conducted household surveys. For someone with hearing or visual impairment, could not fully cooperate, or not at home during home visits, the informant questionnaire on cognitive decline in the elderly (IQCODE) would be used. MMSE (illiteracy ≤17, primary school ≤20, middle school, and above ≤24) and IQCODE ≥3.3 were defined as AD. Hachinski ischemic scale was used to exclude vascular dementia.
2.3. Blood sampling and laboratory tests
Venous blood samples were collected in the morning from participants who agreed. The serum were separated within 30 minutes by centrifugation (4°C, 20 min, 2000 rpm) and transferred in refrigerated boxes to first hospital of Shanxi Medical University, where the samples were stored at −80°C until analyzed. Total Hcy was measured by an enzyme cycling method using a Beckman UniCel DxC 800 Synchron Clinical System Analyzer (Beckman Coulter Inc, CA, USA). Serum folate and vitamin B12 were measured simultaneously by a radio assay kit (MP Biomedical Inc, CA, USA). The concentration unit of serum Hcy, folate, and B12 were μmmol/L, nmol/L, and pmol/L, respectively.
For each case with blood sample, 4 controls were matched with age (±1 years) randomly. Serum Hcy, folate, and B12 were classified into dichotomous variable according to hospital boundaries.
2.4. Quality control
All interviewers were trained strictly by neurologists and psychiatrists. Neurologists and scale evaluator supervised all the progress. Cognitive assessment and blood samples were collected on the same day. The blood samples were taken to our hospital after processing.
2.5. Statistical analyses
The database was set up by the software EpiData3.1, and double input method was adopted. All the data were analyzed by SPSS22.0. Prevalence was calculated and presented as percentages. The Mann-Whitney U test was used to compare continuous variables. Differences between categorical variables were calculated using chi-square test. Conditional logistic regression was used to estimate associations between serum tHcy, folate, B12, and AD. The adjusted odds ratios (aORs) were calculated after controlling sex, education, smoking, and drinking status. A P value <.05 was considered to be statistically significant.
3. Results
There were 6338 eligible residents in the list of the 3 towns in Lüliang area. A total of 4605 (72.66%) were participated in our study. Age and sex distributions of targeted population and participants are presented in Table 1. Of the participants, 51.1% were women. As the age increased, the proportion of population was getting smaller and smaller, 50.73% between 55 and 64 years, 30.45% between 65 and 74 years, 16.61% between 75 and 84 years, and 2.21% older than 85 years. A total of 2103 (45.67%) were illiterate; 39.07% were current smokers and 6.32% were current drinkers.
Table 1.
Age and sex distribution of targeted population and participants.
In Table 2, 396 were finally considered to be AD. The crude prevalence of AD in people older than 55 years living in Lüliang area was 8.60%. The prevalence of AD increased from 5.31% to 17.64% with advancing age. Moreover, the prevalence of women (11.13%) was about twice that of men (5.60%).
Table 2.
Prevalence of cognitive impairment in different age and sex groups.
A total of 1845 residents donated blood samples. The proportion of high Hcy, low folate, and low B12 was 71.70%, 57.74%, and 49.81%, respectively. One hundred eighty-two cases were included from the 1845 residents. For each case, 4 controls were matched with age (±1 years) randomly. The characteristics of cases and controls are shown in Table 3. The mean age of cases and controls were 68.84 ± 7.63 and 68.86 ± 7.69 years. There were much more women in case group (72.53%) than in the controls (41.76%) (P < .001). The cases had a lower education level (P = .001), in other words, there was 68.13% illiteracy in cases compared with the controls (47.8%) (P < .001). The proportion of smokers and drinkers was lower in cases than that in controls (P = .003, P = .001). There were significant differences in serum Hcy and B12 between the 2 groups (P < .001). The cases had a higher proportion of abnormal Hcy and B12 (P = .009, P = .002). These, however, had not been observed in folate (P = .353, P = .140).
Table 3.
The characteristics of cases and controls.
In conditional logistic regression analysis, after controlling sex, education, smoking, and drinking status, we found that the higher level of serum Hcy was associated with a high risk of AD [aOR: 2.083, 95% confidence interval (CI): 1.238–3.505, P = .006], and high folate and B12 levels were protective factors (aOR: 0.538, 95% CI: 0.324–0.893, P = .016; aOR: 0.493, 95% CI: 0.311–0.783, P = .003). Furthermore, high education level was also a protective factors (P < .05). Smoking and drinking were not associated with AD in this population (P > .05) (Table 4).
Table 4.
Conditional logistic regression analyses of cognitive impairment and plasma tHcy, folate, and B12.
4. Discussion
In the present study, the participants represented the entire population well according to the sex ratio and age distribution (Table S1). As the age increases, the number of people was getting smaller and smaller, which was in line with the general law. Because of underdevelopment, the level of education in this area was relatively low, nearly half of participants were illiterate. Smokers were also very common in this area. During our investigation, the diagnosis of AD was made by 2 neurologists to ensure the accuracy.
The prevalence of AD in the European elderly population was 4.4%.[14] The prevalence of AD ≥65 years old in Japan were 2.9% to 3.6%.[15] In our country, Zhang et al[16] surveyed Beijing, Shanghai, Xi’an and Chengdu, the prevalence of AD was 3.5%, north was higher than the south (4.2% vs 2.8%). Jia et al found that the prevalence was 3.21%, 4.25% in rural area compared with 2.44% in city. Our findings showed that the prevalence of AD of people older than 55 years in Lüliang area was approximately 8.60%, which were higher than previous studies and may have a lot to do with rural area, poor transportation, and low education level. The prevalence of AD in the present population increased with age, meanwhile, the prevalence of women was about twice that of men, which were consistent with previous studies.
Lüliang, a mountainous region, is located in the midwest of Shanxi province. As early as many years ago, epidemiology found the high incidence of neural tube defects in the area was related to B vitamin deficiency.[13] This is a B vitamin deficiency region, where the main diet is chiefly staple food until now. Among participants with blood samples in our study, the median of tHcy was 19.30 μmmol/L, which were much higher than other studies conducted in China before.[17,18] The majority (71.70%) of them were hyperhomocysteinemia and half of them were B vitamins deficiency. The high prevalence and high Hcy level indicated that Hcy may be involved in the pathogenesis of AD. The previous results about the relationship between Hcy and AD were contradictory. Next, we conducted a case-control study to better study the relationship. There were significant differences between Hcy and vitamin B12 levels among cases and controls in this population. In conditional logistic regression analysis, hyperhomocysteinemia was a significant risk factor of AD; folate and vitamin B12 were protective factors, as well as the high education level. Hcy may induce Aβ deposition, Tau protein hyperphorylation, neuronal DNA damage, neuronal autophagy abnormalities, and other mechanisms, eventually leading to the occurrence of AD.[19–22]
The potential benefit of B vitamins has been demonstrated in many studies.[5,23–26] Durga et al[27] reported that 3-year folate supplementation can improve the cognitive function. Folate may be effective for mild to moderate AD.[28] The combination of folate and B12 may achieve more obvious effects in mild cognitive impairment elderly in Ma et al’ study. Animal experiments have also confirmed that supplementation with multivitamin B can improve cognitive function in mice.[29] Several studies, however, reported that the treatment of folate and B12 was uncertain.[30–33] The role of B vitamins need to be further studied. The supplement of vitamins and adjustment of diet structure in this area is still not up to standard, and the low education level may affect implementation.
We investigated the relationship between Hcy and AD in a folate and B12 deficient population for the first time, and provided data supporting the association. Moreover, we proposed valuable interventions. Our study also had some limitations. The blood samples were less than half of the entire population, which may lead to bias; this was just a cross-sectional study, and cannot fully assess the temporal relationship between Hcy and cognitive outcome. A longitudinal study should be conducted to observe the effect of B vitamins supplement.
5. Conclusion
In conclusion, the crude prevalence of AD of people older than 55 years old in Lüliang area was higher than earlier studies. We observed a significant association between serum Hcy concentration and AD in a Chinese folate and B12 deficient population, the result of our study imply that hyperhomocysteinemia was a risk factor of AD. People with higher education level may understand more about reasonable diet structure. Adjustment of diet structure and supplementation of folate and B12 may offer potential therapeutic measures.
Acknowledgment
The authors are grateful to all the participants in this study. The authors appreciate the strong support of the local government and township health centers.
Author contributions
Conceptualization: Yang Li, Wei Zhang, YaRong Zhao.
Data curation: HuaXing Meng.
Investigation: HuaXing Meng, Yang Li, Wei Zhang, XiaoYuan Niu.
Methodology: Huaxing Meng, Yang Li.
Project administration: Junhong Guo, XiaoYuan Niu.
Supervision: HuaXing Meng, Wei Zhang, XiaoYuan Niu, Junhong Guo.
Writing – original draft: HuaXing Meng.
Writing – review and editing: Junhong Guo.
Supplementary Material
Footnotes
Abbreviations: AD = Alzheimer disease, aOR = adjusted odds ratio, CI = confidence interval, Hcy = homocysteine, IQCODE = the informant questionnaire on cognitive decline in the elderly, MMSE = Mini-mental State Examination.
How to cite this article: Meng H, Li Y, Zhang W, Zhao Y, Niu X, Guo J. The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China: a cross-sectional study. Medicine. 2019;98:47(e17970).
Informed consent was obtained from the participants after notifying them about the purpose of the survey.
The authors have no conflicts of interest to disclose.
Supplemental Digital Content is available for this article.
References
- [1].2018 Alzheimer's disease facts and figures. Alzheimers Dement 2018;14:367–429. [Google Scholar]
- [2].Langa KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 2017;177:51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013;9:63–75. [DOI] [PubMed] [Google Scholar]
- [4].Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry 1997;38:305–14. [DOI] [PubMed] [Google Scholar]
- [5].Kim H, Kim G, Jang W, et al. Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment. Nutr J 2014;13:118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Yi X, Feng H, Peng S, et al. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: a meta-analysis. Neurosci Lett 2017;636:190–5. [DOI] [PubMed] [Google Scholar]
- [7].Lei F, Vivian I, Sam S, et al. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. Am J Geriatr Psychiatry 2013;21:164–72. [DOI] [PubMed] [Google Scholar]
- [8].Ma F, Wu T, Zhao J, et al. Plasma homocysteine and serum folate and vitamin B12 levels in mild cognitive impairment and Alzheimer's disease: a case-control study. Nutrients 2017;9:725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Setién-Suero E, Suárez-Pinilla M, Suárez-Pinilla P, et al. Homocysteine and cognition: A systematic review of 111 studies. Neurosci Biobehav Rev 2016;69:280–98. [DOI] [PubMed] [Google Scholar]
- [10].Ansari Z. Homocysteine and mild cognitive impairment: are these the tools for early intervention in the dementia spectrum? J Nutr Health Aging 2016;20:155–60. [DOI] [PubMed] [Google Scholar]
- [11].Kong HY, Cheng DM, Pang W, et al. Homocysteine levels and cognitive function scores measured with MMSE and BCAT of middle-aged and elderly subjects in Tianjin City. J Nutr Health Aging 2013;17:527–32. [DOI] [PubMed] [Google Scholar]
- [12].Christiane R, Ming-Xin T, Joshua M, et al. Plasma homocysteine and risk of mild cognitive impairment. Dement Geriatr Cogn Disord 2009;27:11–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Wang B, Huo J, Huang J, et al. Total diet study on certain nutrients in Shanxi regions with a high incidence of birth defects. Wei Sheng Yan Jiu 2008;37:702–6. [PubMed] [Google Scholar]
- [14].Ringman JM, Medina LD, Yaneth RA, et al. Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. Curr Alzheimer Res 2009;6:341–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;56:1133–42. [DOI] [PubMed] [Google Scholar]
- [16].Zhang ZX, Zahner GE, Roman GC, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005;62:447–53. [DOI] [PubMed] [Google Scholar]
- [17].Ling H, Jing M, Jianghui Z, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr 2007;137:407–13. [DOI] [PubMed] [Google Scholar]
- [18].Boyi Y, Shujun F, Xueyuan Z, et al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients 2014;7:74–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Shirafuji N, Hamano T, Yen SH, et al. Homocysteine increases tau phosphorylation, truncation and oligomerization. Int J Mol Sci 2018;19:891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Vanzin CS, Manfredini V, Marinho AE, et al. Homocysteine contribution to DNA damage in cystathionine β-synthase-deficient patients. Gene 2014;539:270–4. [DOI] [PubMed] [Google Scholar]
- [21].Khayati K, Antikainen H, Bonder EM, et al. The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice. FASEB J 2016;31:598–609. [DOI] [PubMed] [Google Scholar]
- [22].Li JG, Barrero C, Gupta S, et al. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging Cell 2017;16:273–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Lee HK, Kim SY, Sok SR. Effects of multivitamin supplements on cognitive function, serum homocysteine level, and depression of Korean older adults with mild cognitive impairment in care facilities. J Nurs Scholarsh 2016;48:223–31. [DOI] [PubMed] [Google Scholar]
- [24].Mikkelsen K, Stojanovska L, Tangalakis K, et al. Cognitive decline: a vitamin B perspective. Maturitas 2016;93:108–13. [DOI] [PubMed] [Google Scholar]
- [25].Cheng D, Kong H, Wei P, et al. B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia. Nutr Neurosci 2016;19:461–6. [DOI] [PubMed] [Google Scholar]
- [26].Madsen SK, Rajagopalan P, Joshi SH, et al. Higher homocysteine associated with thinner cortical gray matter in 803 ADNI subjects. Neurobiol Aging 2015;36: suppl 1: S203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Durga J, Van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369:208–16. [DOI] [PubMed] [Google Scholar]
- [28].Chen H, Liu S, Ji L, et al. Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: a randomized controlled trial. Mediators Inflamm 2016;2016:5912146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Yu L, Chen Y, Wang W, et al. Multi-vitamin B supplementation reversesâ hypoxia-induced tau hyperphosphorylation and improves memory function in adult mice. J Alzheimers Dis 2016;54:297–306. [DOI] [PubMed] [Google Scholar]
- [30].Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012;29:133–49. [DOI] [PubMed] [Google Scholar]
- [31].Robert C, Derrick B, Sarah P, et al. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am J Clin Nutr 2014;100:657–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Zhang DM, Ye JX, Mu JS, et al. Efficacy of vitamin B supplementation on cognition in elderly patients with cognitive-related diseases. J Geriatr Psychiatry Neurol 2017;30:50–9. [DOI] [PubMed] [Google Scholar]
- [33].Araújo JR, Martel F, Borges N, et al. Folates and aging: Role in mild cognitive impairment, dementia and depression. Ageing Res Rev 2015;22:9–19. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.